Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -1.81% | 175.59 | 0.7% | $1405.98m | |
| PFE | Pfizer Inc. | -1.83% | 50.40 | 0.9% | $1327.23m | |
| ABBV | AbbVie, Inc. | -1.44% | 152.55 | 1.9% | $1169.95m | |
| BMY | Bristol-Myers Squibb Co. | -1.52% | 77.03 | 1.0% | $1169.89m | |
| MRK | Merck & Co., Inc. | -1.02% | 92.05 | 0.7% | $1097.17m | |
| LLY | Eli Lilly & Co. | -1.98% | 295.43 | 1.1% | $859.74m | |
| AZN | AstraZeneca Plc | -3.53% | 63.32 | 1.0% | $489.96m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.09% | 141.90 | 0.0% | $438.60m | |
| VERU | Veru, Inc. | -3.78% | 15.01 | 0.0% | $363.86m | |
| NVS | Novartis AG | -0.27% | 87.68 | 0.2% | $229.58m | |
| GSK | GlaxoSmithKline Plc | -2.42% | 43.63 | 0.2% | $222.90m | |
| HZNP | Horizon Therapeutics Plc | -4.82% | 88.42 | 5.4% | $193.67m | |
| SGEN | Seagen Inc. | -2.42% | 143.00 | 5.7% | $174.55m | |
| NVO | Novo Nordisk A/S | -2.61% | 103.56 | 0.1% | $171.61m | |
| VTRS | Viatris, Inc. | -1.74% | 11.27 | 0.0% | $153.78m |
Company Profile
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.